NPPES file of Aug 9, 2026

Thomas Takashima, PHARM.D.

Pharmacotherapy Pharmacist · Santa Clara, CA

Thomas Takashima, PHARM.D. is a pharmacotherapy pharmacist with a practice address in Santa Clara, California, and NPI 1447337720, issued on Nov 1, 2006. Check the license (California 48281, as entered in NPPES) with the California board that licenses this profession; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1447337720
Name
Thomas Takashima
Credential
PHARM.D.
Primary taxonomy
Pharmacotherapy Pharmacist 1835P1200X
License number
48281 CA
Self-reported in NPPES; status is on the state search
Practice location
710 Lawrence Expy, Santa Clara, CA 95051
Phone
(408) 851-9006
Enumerated
Nov 1, 2006
Record last updated
Dec 28, 2021 (not updated in 5 years: call before relying on the address or phone)
Fax
(408) 851-4259
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 710 Lawrence Expy

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Iype Abraham, M.D.Internal Medicine Physician1578737243
  2. Oren Abramson, MDPediatric Gastroenterology Physician1265511307
  3. Jamie Adiarte, PA-CPhysician Assistant1073824413
  4. Sarah Adut, PHDClinical Psychologist1609484831
  5. Najla Ahmadzia, M.D.Student in an Organized Health Care Education/Training Program1568692580
  6. Farhana Ahmed, MDHospitalist Physician1215110002

Verify Thomas Takashima in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich California board licenses this profession
    Search for license 48281
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Find the California license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

7% fewer Medicare Part D claims than the average pharmacotherapy pharmacist in 2024

369 Medicare Part D claims for 74 beneficiaries, against an average of 395 among the 208 providers of this specialty who prescribed in Part D. Brand-name drugs were 68% of claims.

  1. Thomas Takashima369
  2. Specialty average395

Most prescribed

  1. Humalog59 claims
  2. Humalog Kwikpen U-10043 claims
  3. Ozempic38 claims
  4. Insulin Glargine-Yfgn36 claims
  5. Metformin Hcl Er22 claims
  6. Atorvastatin Calcium18 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Thomas Takashima among 605 pharmacotherapy pharmacist records in California

Thomas Takashima, PHARM.D. is one of 605 pharmacotherapy pharmacist records with a practice address in California. 10% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 8% of them.

  • NPI issued2006 · 8% of these records are older, 60% newer
  • In a Medicare fileYes · 10% of these records are
  • In the CMS Doctors and Clinicians fileNo · 0% of these records are
  • Record last updated2021 · 76% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 1835P1200X and a California practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Pharmacotherapy Pharmacist providers in California

There are 605 pharmacotherapy pharmacist records in California.

The 8 pharmacotherapy pharmacist records with the nearest ZIP codes

  1. Tsunnum Malik, PHARMDSanta Clara, CA 950511619594587
  2. Iqbal GillSanta Clara, CA 950541528467396
  3. Phoebe Lee, PHARMDMilpitas, CA 950351750449864
  4. Len Du, RPHSan Jose, CA 951111760078364
  5. Patrice Lucas, PHARMDSan Jose, CA 951191700083672
  6. Jill Nofziger, PHARMDSan Jose, CA 951191033636998
  7. Jeannie Sohn, PHARM.D.San Jose, CA 951201528199577
  8. May Nguyen, PHARMD.San Jose, CA 951211033665369

Common questions

What is Thomas Takashima, PHARM.D.'s NPI number?

Thomas Takashima, PHARM.D.'s National Provider Identifier (NPI) is 1447337720, issued on Nov 1, 2006. An NPI identifies a provider in billing; it is not a license.

Where is Thomas Takashima, PHARM.D. located?

The NPPES record lists a practice address at 710 Lawrence Expy, Santa Clara, CA, 95051. Phone: (408) 851-9006. Providers update this record themselves, so call before visiting.

How can I verify Thomas Takashima, PHARM.D.'s license?

NPPES lists California license number 48281, as entered by the provider. Search the California board that licenses this profession; the NPPES record confirms identity only.

How much does Thomas Takashima, PHARM.D. prescribe under Medicare Part D?

In 2024, Thomas Takashima, PHARM.D. had 369 Medicare Part D claims for 74 beneficiaries; the average among pharmacotherapy pharmacist prescribers was 395. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.